Summary Box: Amgen & Watson plan biosimilar drugs - BusinessWeek

[INCIID News Feed]

WTNH
<img alt="" height="1" width="1" />
Summary Box: Amgen & Watson plan biosimilar drugs
BusinessWeek
By AP DRUG DEAL: Biotech giant Amgen is partnering with generic drugmaker Watson Pharmaceuticals to produce "biosimilar" medicines for cancer. FUTURE NICHE: US regulators are crafting rules for approval of drugs similar to existings biologic ones. ...
Amgen, Watson Partner to Develop Anticancer BiosimilarsGenetic Engineering News
Amgen Plans to Team Up With Watson on GenericsNew York Times
Amgen, Watson partner to create several &#39;biosimilar&#39; versions of other ...Washington Post
Wall Street Journal -Forbes
all 256 news articles &raquo;


More...